Tube leukocyte adherence inhibition assay : the assessment of tumor immunity in cancer patients and in rats
De leukocyte-adherentie-remmings test : bepaling van tumor immuniteit bij kanker patiënten en ratten
For the past two decades, intensive search has been made for the existence of tumor-specific antigens of human cancer. The recent succesful development of monoclonal antibodies against TAA on human cell membrane has not yet resulted in the identification of any tumor-specific determinant(s) on cancer cells. An alternative approach for the identification of tumor-specific antigens has been to study the immune response of the host to cancer. Cell-mediated cytotoxicity was initially investigated using microcytotoxicity assays (47). Specific cytotoxicity against a variety of cultured cells from human tumors was observed with lymphoid cells from tumor-bearers or individuals whose tumor had been resected. The whole concept of specific cell-mediated cytotoxicity in human cancer was doubted when natural cytotoxicity was discovered (18, 19). However, investigators working with the tumor extract-induced leukocyte adherence inhibition (LA I) phenomenon have successfully provided much of the existing evidence for specific anti-tumor immunity in animals and human cancers (81,82). The ultimate objective of the present study was to use the tube LA! assay to monitor the purification of human TAA from crude tumor extracts. On the assumption that T AA are foreign or modified human major histocompatibility complex antigens (HLA antigens) or are closely associated with these antigens, the biochemical techniques used to study the nature of HLA antigens could be applied to obtain an insight into the biochemical nature of TAA and their relation (if any) to HLA antigens. The tube LAI assay was chosen since it was claimed to be simple, rapid and reproducible. In the first instance it was necessary to develop a reliable tube LAI technique of high sensitivity. In the initial studies it was investigated whether this could be achieved by using partially purified tumor extracts. Since the amount of patient tumor material severely restricted the amount of crude extracts that could be chroma to graphed and purified further using other physico-chemical techniques, LAI studies in rats were also pursued.
|colorectal cancer, immunology, leukocyte adherence inhibition, peripheral blood leukocytes, tumor|
|Erasmus University Rotterdam|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Tank, B. (1985, June 19). Tube leukocyte adherence inhibition assay : the assessment of tumor immunity in cancer patients and in rats. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/38633